Financials

News Discussions Technicals Seasonals

950210 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Prestige BioPharma Ltd. engages in the development and commercialization of biosimilars and antibody therapeutics. The firm develops antibody drugs for solid tumor, pancreatic cancer, and arthritis. Its product portfolio includes Herceptin, Avastin, and Humira biosimilars as well as anti-PAUF and anti-CTHRC1 antibodies. The company was founded in July 2005 and is headquartered in Singapore.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

950210 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company